A relatively new treatment addresses "the root cause of anxiety, depression, PTSD, and Long COVID symptoms," according to the company Stella Global's website, which promotes its use.
The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy” on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results